Core Viewpoint - The AI Fund Shangyin Medical Health Mixed A (011288) reported a profit of 23.8046 million yuan for the first half of 2025, with a weighted average profit per fund share of 0.1545 yuan, and a net value growth rate of 27.48% during the reporting period [2]. Fund Performance - As of September 3, the fund's net value growth rates were 26.39% over the past three months, 50.44% over the past six months, 69.76% over the past year, and 33.48% over the past three years, ranking 56/138, 54/138, 51/136, and 37/108 among comparable funds respectively [5]. - The fund's net value as of September 3 was 0.904 yuan per unit [2]. Fund Holdings and Valuation - As of June 30, 2025, the fund's weighted average price-to-earnings (P/E) ratio was approximately 110.14 times, compared to the industry average of 120.96 times; the weighted average price-to-book (P/B) ratio was about 5.11 times, against an industry average of 4.07 times; and the weighted average price-to-sales (P/S) ratio was around 6.86 times, compared to an industry average of 6.52 times [11]. - The fund's stocks showed a weighted revenue growth rate of 0.02% year-on-year and a weighted net profit growth rate of -0.01% for the first half of 2025 [18]. Fund Management and Strategy - The fund manager, Yang Jiannan, expressed optimism about the ongoing innovation drug market and highlighted potential in companies with new product launches and those benefiting from a reversal in the innovation cycle [2]. - As of June 30, 2025, the fund had a total of 1,958 holders, with a total of 149 million shares held, where institutional investors accounted for 18.64% and individual investors for 81.36% [35]. Risk and Return Metrics - The fund's Sharpe ratio over the past three years was 0.1767, ranking 35/105 among comparable funds [24]. - The maximum drawdown over the past three years was 35.07%, with the largest quarterly drawdown occurring in Q1 2024 at 20.49% [26].
上银医疗健康混合A：2025年上半年利润2380.46万元 净值增长率27.48%
Sou Hu Cai Jing·2025-09-05 09:40